(secondQuint)VitaFlowTM II Transcatheter Aortic Valve System Study.

 This is a prospective, multicenter, single arm and controlled clinical investigation compared to recent historical results.

 The purpose is to evaluate the safety, performance and efficacy of the VitaflowTM II Transcatheter Aortic Valve system.

 The entire system including valve system, delivery system and introducer system.

 We will implant the valve system into subjects and followed up them for 5 years after the procedure.

 This clinical trial will be conducted in 15 sites in Europe.

.

 VitaFlowTM II Transcatheter Aortic Valve System Study@highlight

A prospective, single arm clinical investigation evaluating safety and effectiveness/performance of the Microport CardioFlow VitaFlowTM II - Transcatheter Aortic Valve System for the treatment of symptomatic severe aortic stenosis via transcatheter access in increased surgical risk patients